Drug Shortage Report for METHOTREXATE INJECTION BP
Report ID | 247130 |
Drug Identification Number | 02474891 |
Brand name | METHOTREXATE INJECTION BP |
Common or Proper name | METHOTREXATE SODIUM |
Company Name | ACCORD HEALTHCARE INC |
Market Status | MARKETED |
Active Ingredient(s) | METHOTREXATE |
Strength(s) | 25MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 40ML |
ATC code | L01BA |
ATC description | ANTIMETABOLITES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2025-01-08 |
Estimated end date | 2025-04-18 |
Actual end date | 2025-04-11 |
Shortage status | Resolved |
Updated date | 2025-04-12 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | Customer Service at (514) 505-4159 ext. 203 | Service à la clientèle à (514) 505-4159 poste 203 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2025-04-12 | English | Compare |
v9 | 2025-04-11 | French | Compare |
v8 | 2025-04-11 | English | Compare |
v7 | 2025-03-07 | French | Compare |
v6 | 2025-03-07 | English | Compare |
v5 | 2025-01-31 | French | Compare |
v4 | 2025-01-31 | English | Compare |
v3 | 2025-01-09 | English | Compare |
v2 | 2025-01-08 | French | Compare |
v1 | 2025-01-08 | English | Compare |
Showing 1 to 10 of 10